[Federal Register Volume 86, Number 49 (Tuesday, March 16, 2021)]
[Notices]
[Pages 14471-14472]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-05356]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-805]


Importer of Controlled Substances Application: Purisys, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Purisys, LLC has applied to be registered as an importer of 
basic class(es) of controlled substance(s). Refer to Supplementary 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before April 15, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before April 15, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on February 17, 2021, Purisys, LLC, 1550 Olympic Drive, 
Athens, Georgia 30601, applied to be registered as an importer of the 
following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
 
------------------------------------------------------------------------
Marihuana Extract.....................       7350  I
Marihuana.............................       7360  I
Tetrahydrocannabinols.................       7370  I
Noroxymorphone........................       7379  II
Phenylacetone.........................       8501  II
Levorphanol...........................       9220  II
Thebaine..............................       9333  II
Poppy Straw Concentrate...............       9670  II
Tapentadol............................       9780  II
------------------------------------------------------------------------

    The company plans to import drug code 8501, Phenylacetone and drug 
code 9670, Poppy Straw Concentrate to bulk manufacture other controlled 
substances for distribution to its customers. The company plans to 
import impurities of buprenorphine that have been determined by DEA to 
be captured under drug code 9333, Thebaine. In reference to drug codes 
73760, Marihuana and 7370, Tetrahydrocannabinols the company plans to 
import a Synthetic Cannabidiol and a Synthetic Tetrahydrocannabinol. No 
other activity for these drug codes is authorized for this 
registration. Placement of these drug codes on the company's 
registration does not translate into automatic approval of subsequent 
permit applications to import controlled substances.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-

[[Page 14472]]

approved finished dosage forms for commercial sale.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-05356 Filed 3-15-21; 8:45 am]
BILLING CODE 4410-09-P